CAPRCapricor Therapeutics, Inc.
What is the market doing?
No clear lean: nothing decisive, though a crowded short (+34% of shares).
Rangebound, no clear trend. Price is −66% vs its 200-day average.
A crowded short, settled Sep 15, 2026, about a week of normal trading to cover. Down 11% since the previous count, up from 20.4% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CAPR is trading
Capricor Therapeutics, Inc. is +229% over the past year while the S&P 500 is +18%: 210 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −66%
vs 200-day average · a clear downtrend
- RSI (14)
- 40
RSI (14) · neutral
- Below its 52-week high
- 78%
Below its 52-week high
Details›
- Last close2026-10-09
- $30.40
- 1 monthS&P 500 +2.7%
- +3.5%
- 1 yearS&P 500 +18%
- +229%
- 5 yearsS&P 500 +88%
- +501%
- vs 50-day average$7.69
- +1.9%
- 52-week high
- $35.34
- 52-week low
- $3.83
- Annualised volatility
- 296%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$1.5M
| Year | Return |
|---|---|
| 2026 (year to date) | −73% |
| 2025 | +109% |
| 2024 | +182% |
| 2023 | +27% |
| 2022 | +32% |
| 2021 | −15% |
| 2020 | +168% |
| 2019 | −69% |
| 2018 | −74% |
| 2017 | −41% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +15% |
| Feb | 10 | 6 of 10 | +2.2% |
| Mar | 10 | 5 of 10 | −1.4% |
| Apr | 10 | 5 of 10 | +48% |
| May | 10 | 3 of 10 | −16% |
| Jun | 10 | 7 of 10 | +3.1% |
| Jul | 11 | 4 of 11 | +1.2% |
| Aug | 11 | 6 of 11 | +5.2% |
| Sep | 11 | 5 of 11 | +36% |
| Oct | 11 | 1 of 11 | −11% |
| Nov | 10 | 3 of 10 | −11% |
| Dec | 10 | 2 of 10 | +34% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.